$TRU

Needham maintains Buy rating on TransUnion, $95 price target

Needham kept a Buy rating on TransUnion with a $95 price target, suggesting a 26% upside from the last close. The firm cited strong international revenue growth, particularly in Latin America and India, and effective capital management through stock buybacks totaling $243 million year-to-date.

Original reporting
Published Oct 28, 2026, 10:18 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 10:27 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Needham maintains Buy rating on TransUnion, $95 price target — source image
Decision brief

The 30-second read

$TRUBullishLow
01

Why it matters

The combination of strong international performance and capital return strategy reinforces a bullish outlook.

02

Market read

Analyst rating and target provide a modest catalyst for TRU, likely generating short‑term buying pressure.

03

What to watch

Potential headwinds in the U.S. mortgage market could offset international growth momentum.

Relevance 5/10Novelty 4/10Timing: pre‑market today

Background

Needham's analyst note emphasizes TransUnion's 12% YoY revenue growth abroad and $243 M of buybacks in 2026.

Company-level read

Ticker impact

$TRUBullishMedium confidence
Context

Needham maintained its Buy rating on TransUnion and set a new $95 price target, implying a 26% upside.

Expected impact

likely modest upward pressure as investors price in the $95 target

Evidence & confidence

The rating is unchanged but the explicit target provides a clear upside thesis, prompting short‑term buying interest.

Market effects

Supports positive sentiment for the credit‑reporting sector as analysts highlight international growth.

Neutral for broader US market; may slightly boost financial services indices.

Limited; primarily affects US investors focused on TransUnion.

Counterpoint

Some investors may view the unchanged rating as a sign of limited upside despite the higher target.

Key entities

  • TransUnion

    U.S. credit reporting firm (ticker TRU).

  • Needham

    Equity research firm providing the rating and price target.

Related articles

$TRUHighAI 8/10

TransUnion (TRU) (Q3 2026) Earnings Call Highlights: Revenue and EPS Beat Guidance

TransUnion (TRU) reported Q3 2026 earnings beating guidance with 8% revenue growth and 14% EPS growth. International business grew 10%, led by India and Latin America. The company reduced its leverage ratio and increased share repurchase authorization. However, rising interest rates are expected to slow mortgage volumes and auto affordability, leading to a sequential deceleration in revenue growth to 3-6% in Q4. Legal and regulatory expenses also contributed to margin contraction.

$TRUHighAI 8/10

TransUnion (TRU) Q3 2026 Earnings Call Transcript

TransUnion (TRU) reported Q3 2026 organic revenue growth of 8%, with adjusted EPS up 14%. U.S. Markets revenue rose 7%, while international revenue grew 10%, led by India and Latin America. The company repurchased $126M in shares and raised its repurchase authorization by $1B. Despite economic uncertainties, TRU raised its full-year guidance, expecting 8-9% revenue growth and 12-13% adjusted EPS growth.

$TRUMed

TransUnion Q3 2026 Earnings Call Summary

TransUnion reported Q3 2026 earnings, highlighting 18% growth in India and Latin America, 13% auto growth, and 10% international growth. The company expects full-year share repurchases of $500M and plans to expand its OneTru platform globally. Management noted resilience in US Financial Services despite inflation and higher interest rates, and provided guidance for Q4, including potential impacts from regulatory changes and market softening.

$TRUHighAI 8/10

TransUnion Q3 2026 slides: insurance drives growth amid margin pressure

TransUnion (TRU) reported Q3 2026 earnings with revenue of $1.31B, matching estimates, and EPS of $1.25, beating forecasts. Revenue grew 8% organically, driven by insurance and international markets. However, adjusted EBITDA margin contracted by 90 basis points to 35.4%. The company raised full-year guidance, expecting 8-9% revenue growth and 12-13% EPS growth. Shares fell 2.19% in premarket trading.